Bristol-Myers Squibb Company
PD-L1 binding polypeptides for imaging

Last updated:

Abstract:

Provided herein are novel polypeptides comprising fibronectin type III tenth (.sup.10Fn3) domains which specifically bind to Programmed Death Ligand-1 (PD-L1), as well as imaging agents based on the same for diagnostics.

Status:
Grant
Type:

Utility

Filling date:

24 Nov 2015

Issue date:

10 Sep 2019